MKNK2 and neoplasm: Based on the findings that Mnk2a acts as a tumor suppressor and its production competes with the production of the oncogenic Mnk2b isoform, we focused our efforts on the manipulation of MKNK2 alternative splicing to induce Mnk2a formation, in order to inhibit cancer cell growth and survival.